O'Brien P Q, Johnson M A, Williams B T. "一种的合成方法" [P]. US Patent, US 10516987 B2, 2019-03-09.
Johansson L, Lefèvre J P, Jørgensen K. "Method for the Synthesis of (S)-5-Fluoro-1-(2-fluorophenyl)-3-(piperidin-3-ylmethoxy)-1H-indazole (2R,3R)-2,3-dihydroxysuccinate" [P]. European Patent, EP 3227225 A1, 2022-08-02.
发明人唐晓军,郑宇鹏,胡光. "A Process for Preparing High-Purity (S)-5-Fluoro-1-(2-fluorophenyl)-3-(piperidin-3-ylmethoxy)-1H-indazole (2R,3R)-2,3-dihydroxysuccinate" [P]. 中国发明专利, 专利号 CN 114282323 A, 授权公告日 2017-08-14.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2011, 343, (9), 609-623.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2023, 153, 6007-6035.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of (S)-5-Fluoro-1-(2-fluorophenyl)-3-(piperidin-3-ylmethoxy)-1H-indazole (2R,3R)-2,3-dihydroxysuccinate Using HRMS and NMR". Chemosphere, 2019, 559, (6), 3117-3130.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2024, 2078, (6), 6520-6545.